Search Results
Nov 19, 2025, 07:04 ET Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
Labcorp Plasma Detect, a tumor-informed, blood-based assay used to detect molecular residual disease (MRD) from circulating tumor DNA (ctDNA), was featured in two recent peer-reviewed publications –
More news about: Labcorp
Nov 19, 2025, 07:03 ET Workplace Health 2030: Godrej Industries Group and Global Partners aim to redefine well-being for new era of work
Health 2030', is uniting global voices to move beyond traditional wellness and embed vitality, mental health parity, and ESG-linked metrics into the DNA of every organization. Our collaboration with Godrej Industries Group and Arogya World in Mumbai is a powerful demonstration that 'Good Health is Good
More news about: Godrej Industries Group
Nov 18, 2025, 19:00 ET Introducing the All-new, All-electric 2026 Jeep® Recon: Trail Rated Capability, Electrified
precise control from the first touch of the throttle, accelerating from 0 to 60 mph in as little as 3.6 seconds. It's a bold, new expression of Jeep brand DNA, electrified and trail ready with an estimated all-electric range of up to 250 miles (based on trim). "The 2026 Jeep Recon is
More news about: Stellantis
Nov 18, 2025, 12:39 ET DNA&STONE EXPANDS CREATIVE LEADERSHIP WITH ADDITION OF ALISON FORSYTHE AND JASON FONG AS CREATIVE DIRECTORS
www.dnaandstone.com. About DNA&STONEDNA&STONE is a full-service creative agency that doesn't flinch—for brands that go there. Grounded in a proprietary strategic approach called Radical Empathy, DNA&STONE goes beyond just understanding, to feeling the experiences,
More news about: DNA&STONE
Nov 18, 2025, 10:50 ET MiRNA Microarray Kits And Reagents Market Surges to USD 2.45 Billion by 2033, Propelled by 8.5% CAGR - Verified Market Reports®
Global Nucleic Acid Labeling Market Size By Type (DNA Labeling, RNA Labeling), By Labeling (Radioactive Labeling, Fluorescent Labeling), By Application (Diagnostics, Research and Development), By Product
More news about: Verified Market Reports
Nov 18, 2025, 10:22 ET K38 Seaboard Station Celebrates Grand Opening with Ribbon Cutting, Live Music, Free Small Queso, a Savage Surfboard Raffle, and Family Fun
creating a space that feels like a true extension of the coast — where guests can relax, connect, and experience the hospitality that's been part of our DNA for more than 30 years." Located at Seaboard Station, Raleigh, K38 joins the Live.Eat.Surf restaurant family, which includes
More news about: K38
Nov 18, 2025, 09:30 ET Smartwebs Partners with Payabli to Power Payment Distribution and Expand Accounts Payable Capabilities
a payables solution their customers actually need. When you find a partner who shares your values and puts their customers first, you've got all the DNA of a great partnership." - Jo Phillips, Co-CEO / Co-Founder. As the HOA industry continues to expand, now encompassing over 400,000
More news about: Smartwebs, Inc.
Nov 18, 2025, 09:00 ET Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights
duet multiomics solutions, enabling researchers to access comprehensive genetic and epigenetic insights from a single DNA sample.
More news about: Zymo Research Corp.
Nov 18, 2025, 09:00 ET Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights
duet multiomics solutions, enabling researchers to access comprehensive genetic and epigenetic insights from a single DNA sample.
More news about: Zymo Research Corp.
Nov 18, 2025, 09:00 ET Zymo Research gibt strategische Partnerschaft mit biomodal bekannt, um Multiom-Erkenntnisse der nächsten Generation zu liefern
Duet-Multiomik-Lösungen von biomodal anzubieten, wodurch Forscher aus einer einzigen DNA-Probe umfassende genetische und epigenetische Erkenntnisse gewinnen können.
More news about: Zymo Research Corp.
Nov 18, 2025, 09:00 ET Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
technology for protein and other multiomic analysis, the companies will work together to leverage the SBX technology to enhance Freenome's cell-free DNA (cfDNA) cancer screening tests. Freenome will also gain access to Roche plasma sample cohorts that will help accelerate development of personalized screening
More news about: Freenome Holdings, Inc.
Nov 18, 2025, 09:00 ET Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Nov 18, 2025, 08:30 ET Biomarker Testing: Pushing the Limits of Ultrasensitivity, Upcoming Webinar Hosted by Xtalks
Capture antibody (Ab) was conjugated to a partially double-stranded DNA fragment containing a poly-A tail and a target-specific molecular identifier (TMI), while detection Ab was conjugated to another partially double-stranded DNA fragment carrying a biotin group and a matching TMI. After controlling
More news about: Xtalks
Nov 18, 2025, 08:05 ET INOVIO to Participate in December Investor Conferences
biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting
More news about: INOVIO Pharmaceuticals, Inc.
Nov 18, 2025, 08:00 ET Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
antibiotics underscore the necessity to develop therapeutics that have a novel mode of action. DNA replication is a process that can be successfully targeted by small molecules. Ibezapolstat, an inhibitor of the replicative DNA polymerase pol IIIC from Gram- positive bacteria identified by screening library of
More news about: Acurx Pharmaceuticals, Inc.
Nov 18, 2025, 08:00 ET Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health
BOSTON, Nov. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year initiative funded
More news about: Ginkgo Bioworks
Nov 18, 2025, 07:30 ET Pixelgen Technologies Appoints Dr. Aaron Viny to Scientific Advisory Board
"Dr. Viny's groundbreaking research into how the 3-D 'architecture' of DNA goes awry in blood cancers like acute myeloid leukemia is helping shape a new generation of targeted therapies for patients who today have few or no
More news about: Pixelgen Technologies
Nov 18, 2025, 07:19 ET Monteloeder Botanical Nutricosmetic Clinically Supports Younger Looking Skin
balanced melanin process, and contributes to telomere integrity. Widely recognized as a crucial biomarker of ageing, telomeres are DNA sequences that shield chromosomes as cells divide. Telomeres typically shorten with time, signaling cell decline and ageing. This negatively impacts
More news about: Monteloeder, S.L.
Nov 18, 2025, 07:00 ET BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
In addition, BioLineRx has established a joint venture with Hemispherian AS to develop GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other solid tumors, for which a Phase 1/2a clinical trial is planned to be initiated in the first quarter of 2026.
More news about: BioLineRx Ltd.
Nov 17, 2025, 16:01 ET Tepia Turns 13: Orange County Mobile App Firm Highlights Human First Development
was handpicked, not only for skill but for alignment with a culture centered on accountability and client trust. That approach shaped the company's DNA and helped it navigate challenges along the way. Growth brought roadblocks. Adapting to shifting technologies,
More news about: Tepia
Nov 17, 2025, 13:00 ET Hyundai Design Team Creatively Mixes Work and Play in 'The Sandbox' to Develop Better XRT Vehicles
Unique XRT creative space created by the same designers who bring cohesive design DNA into every XRT product IRVINE,
More news about: Hyundai Motor America
Nov 17, 2025, 12:01 ET KATE SPADE NEW YORK KICKED OFF THE HOLIDAY SEASON WITH A STAR-STUDDED CELEBRATION AT CHATEAU MARMONT HOSTED BY ICE SPICE AND LAUFEY
delivering seasonal collections of handbags, ready-to-wear, jewelry, footwear, gifts, home décor and more. Known for its rich heritage and unique brand DNA, Kate Spade New York offers a distinctive point of view and celebrates communities of women around the globe who live their perfectly imperfect lifestyles.
More news about: Kate Spade New York
Nov 17, 2025, 11:57 ET Resolve Therapeutics to Present at International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS)
RSLV-132 and RSLV-145. The compounds are being investigated in a broad range of acute and chronic diseases known to be driven by cell-free RNA, cell-free DNA, and Neutrophil Extracellular Traps (NETs). For more information please visit:
More news about: Resolve Therapeutics, LLC
Nov 17, 2025, 11:06 ET AI Trends 2026 Report: Risk, Agents, and Sovereignty Will Shape the Next Wave of Adoption, Says Info-Tech Research Group
manage AI in 2026: Foundational AI Principles Will Rewrite Organizational DNAOrganizations are formalizing AI principles that align technology decisions with enterprise values, ensuring that innovation remains transparent,
More news about: Info-Tech Research Group
Nov 17, 2025, 10:20 ET Precision Nutrition Market Expected to Reach USD 22.82 Billion by 2032 Amid Rapid Advances in Genomics, Biomarker Science & Digital Health Platforms | DataM Intelligence
Rising D2C adoption: More than 35% of consumers using nutrition services now prefer personalized plans powered by biomarker and DNA insights. Digital health surge: Precision nutrition apps, wearables, and metabolic tracking platforms
More news about: DataM Intelligence 4 Market Research LLP